Literature DB >> 10968595

Is antenatal group B streptococcal carriage a predictor of adverse obstetric outcome?

S M Garland1, N Kelly, A M Ugoni.   

Abstract

OBJECTIVES: While early-onset neonatal GBS sepsis is positively associated with premature birth and prolonged rupture of membranes, there is debate in the literature as to whether maternal GBS colonization is a predictor of adverse obstetric outcome. This is a critical issue to resolve for appropriate management (expectant vs. interventional management) of the patient presenting with premature rupture of membranes, who has no overt signs of sepsis, but who is colonized with GBS.
METHODS: Since 1981 it has been hospital policy to screen all public patients antenatally for genital carriage of GBS by collection of a low vaginal swab at 28-32 weeks. All patients colonized with GBS antenatally are given penicillin as intrapartum chemoprophylaxis. Review of all GBS-colonized antenatal patients for a 12-month period (580 of 4,495 patients) and a randomized (every fourth consecutive antenatal patient) number of noncolonized patients (958) was made. Lower vaginal GBS colonization and other risk factors for preterm delivery were assessed using univariate and multivariate generalized linear modeling.
RESULTS: In the study group, the maternal GBS colonization rate was 12.9%. When cofounding variables were controlled in a multivariate analysis, the association between antepartum GBS colonization and preterm labor and preterm rupture of membranes was not significant.
CONCLUSION: Maternal antenatal carriage of GBS does not predict preterm labor. Therefore it is appropriate that expectant management occur for a GBS-colonized woman who ruptures her membranes, is not in labor, and has no evidence of sepsis.

Entities:  

Mesh:

Year:  2000        PMID: 10968595      PMCID: PMC1784688          DOI: 10.1155/S106474490000017X

Source DB:  PubMed          Journal:  Infect Dis Obstet Gynecol        ISSN: 1064-7449


  21 in total

1.  Preterm premature rupture of membranes: results of expectant management in patients with cervical cultures positive for group B streptococcus or Neisseria gonorrhoeae.

Authors:  G L Maxwell; W J Watson
Journal:  Am J Obstet Gynecol       Date:  1992-03       Impact factor: 8.661

2.  Genital Group B Streptococcus carriage in the antenatal period: its role in prom and preterm labour.

Authors:  S Chua; S Arulkumaran; C Chow; G Kumarasinghe; N Selamat; B G Kuah; S S Ratnam
Journal:  Singapore Med J       Date:  1995-08       Impact factor: 1.858

3.  Prevalence proportion ratios: estimation and hypothesis testing.

Authors:  T Skov; J Deddens; M R Petersen; L Endahl
Journal:  Int J Epidemiol       Date:  1998-02       Impact factor: 7.196

4.  Vaginal Bacteroides species are associated with an increased rate of preterm delivery among women in preterm labor.

Authors:  M A Krohn; S L Hillier; M L Lee; L K Rabe; D A Eschenbach
Journal:  J Infect Dis       Date:  1991-07       Impact factor: 5.226

5.  Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis.

Authors:  K M Boyer; S P Gotoff
Journal:  N Engl J Med       Date:  1986-06-26       Impact factor: 91.245

6.  Early onset neonatal group B streptococcus (GBS) infection: associated obstetric risk factors.

Authors:  S M Garland
Journal:  Aust N Z J Obstet Gynaecol       Date:  1991-05       Impact factor: 2.100

7.  Microbiologic causes and neonatal outcomes associated with chorioamnion infection.

Authors:  S L Hillier; M A Krohn; N B Kiviat; D H Watts; D A Eschenbach
Journal:  Am J Obstet Gynecol       Date:  1991-10       Impact factor: 8.661

8.  Rupture of fetal membranes and premature delivery associated with group B streptococci in urine of pregnant women.

Authors:  M Møller; A C Thomsen; K Borch; K Dinesen; M Zdravkovic
Journal:  Lancet       Date:  1984-07-14       Impact factor: 79.321

9.  Group B streptococcal colonization and preterm labour.

Authors:  H McDonald; R Vigneswaran; J A O'Loughlin
Journal:  Aust N Z J Obstet Gynaecol       Date:  1989-08       Impact factor: 2.100

10.  Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. II. Predictive value of prenatal cultures.

Authors:  K M Boyer; C A Gadzala; P D Kelly; L I Burd; S P Gotoff
Journal:  J Infect Dis       Date:  1983-11       Impact factor: 5.226

View more
  6 in total

Review 1.  Preterm birth due to maternal infection: Causative pathogens and modes of prevention.

Authors:  M V Pararas; C L Skevaki; D A Kafetzis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-09       Impact factor: 3.267

2.  Frequency of Group B Streptococcal Colonization in Pregnant Women Aged 35- 37 Weeks in Clinical Centers of Shahed University, Tehran, Iran.

Authors:  Shahrzad Hadavand; Fatemeh Ghafoorimehr; Leila Rajabi; Ali Davati; Nafiseh Zafarghandi
Journal:  Iran J Pathol       Date:  2015

3.  Preclinical Evaluation of Tolerability of a Selective, Bacteriostatic, Locally Active Vaginal Formulation.

Authors:  Luca Ivan Ardolino; Marisa Meloni; Giuseppe Brugali; Emanuela Corsini; Corrado Lodovico Galli
Journal:  Curr Ther Res Clin Exp       Date:  2016-07-25

4.  Prevalence and Risk Factors of Group B Streptococcus Colonization in Pregnant Women: A Pilot Study in Palestine.

Authors:  Mohammad Qadi; Adham AbuTaha; Ro'ya Al-Shehab; Salsabil Sulaiman; Abdallah Hamayel; Amjad Hussein; Shatha AbuTaha; Ayman Dawoud; Faizeh Hussein
Journal:  Can J Infect Dis Med Microbiol       Date:  2021-12-13       Impact factor: 2.471

5.  The prevalence of vaginal microorganisms in pregnant women with preterm labor and preterm birth.

Authors:  Seong Jin Choi; Soon Deok Park; In Ho Jang; Young Uh; Anna Lee
Journal:  Ann Lab Med       Date:  2012-04-18       Impact factor: 3.464

Review 6.  Preterm Birth Associated With Group B Streptococcus Maternal Colonization Worldwide: Systematic Review and Meta-analyses.

Authors:  Fiorella Bianchi-Jassir; Anna C Seale; Maya Kohli-Lynch; Joy E Lawn; Carol J Baker; Linda Bartlett; Clare Cutland; Michael G Gravett; Paul T Heath; Margaret Ip; Kirsty Le Doare; Shabir A Madhi; Samir K Saha; Stephanie Schrag; Ajoke Sobanjo-Ter Meulen; Johan Vekemans; Craig E Rubens
Journal:  Clin Infect Dis       Date:  2017-11-06       Impact factor: 9.079

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.